Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Myoung Hwa KimYoung Chul YooSun Joon BaiKang-Young LeeNayeon KimKi Young LeePublished in: The Journal of international medical research (2021)
HIPEC increased patients' body temperature and cardiac output and decreased systemic vascular resistance. Although parameters that were extracted from the VolumeView™ system were within their normal ranges, transpulmonary thermodilution approach is helpful in intraoperative hemodynamic management during open abdominal cytoreductive surgery with HIPEC.Trial registry name: ClinicalTrials.govTrial registration number: NCT02325648URL: https://clinicaltrials.gov/ct2/results?cond=NCT02325648&term.
Keyphrases
- minimally invasive
- patients undergoing
- end stage renal disease
- coronary artery bypass
- chronic kidney disease
- ejection fraction
- newly diagnosed
- clinical trial
- computed tomography
- study protocol
- prognostic factors
- left ventricular
- preterm infants
- peritoneal dialysis
- metastatic renal cell carcinoma
- squamous cell carcinoma
- magnetic resonance imaging
- contrast enhanced
- image quality
- heart failure
- locally advanced
- patient reported outcomes
- positron emission tomography
- gestational age
- double blind